The Seed Industry in the Next Decade: Transgenic Technology Holds the Line, Gene Editing Breaks the Impasse, and China Remains a Key Variable

“Genetic modification determines yield, gene editing and other technologies shape quality, while regulation will define the future.” This is no longer a mere prediction—it has become the core logic of the new era in global seed‑industry competition. In this new cycle of “stable growth plus technological acceleration,” China is transitioning from the world’s largest food‑demand market into a formidable “technological force” that can no longer be ignored, fully joining the fray to reshape the global seed‑industry landscape.

Market Fundamentals: Shifting from “Area-Driven” to “Technology-Driven”

From 1996 to 2024, the global commercial seed market grew by a factor of 3.5. However, the underlying growth dynamics have fundamentally shifted: in the past, yield was determined by the area of arable land; today, it is technology that defines the value of seeds.

In 2024–2025, global planted area remained virtually unchanged (-0.1%), with the sole growth driver being a 2.5% increase in corn acreage. Soybean acreage saw only modest expansion, largely unaffected by U.S. regulatory constraints. The real catalyst for growth in the seed industry is the “technological enhancement of seed prices.”

European data show that 74% of the increase in crop yields stems from genetic improvement, not from expanded land use. S&P forecasts that, between 2025 and 2035, the global seed industry will maintain an average annual growth rate of 2.2%, with innovation driving growth rather than increases in planted acreage.

Industry Evolution: From Mergers to Specialization

The global seed industry is undergoing a major transformation, with a shift from large-scale “corporatization” toward high degrees of “specialization.”

Phase I (2015–2018)—The Era of Corporate Consolidation: Large-scale mergers and acquisitions reshaped the industry; Phase II (post-2018)—A Shift Toward Specialization: Corporations began strategically divesting non-core businesses; Phase III (from 2024 onward)—The Seed Industry Revitalization Strategy and the Rise of Regional Powerhouses: Developing‑country seed companies such as GDM and Longping High-Tech have risen rapidly.

GDM projects its sales to grow from US$200 million in 2014 to US$1.8 billion by 2026, and it has now become one of the world’s top six seed companies. Longping High-Tech has also risen to the ranks of the world’s top seven seed companies. Despite the continuous entry of new players, the combined market share of the top 12 seed companies remained stable between 2014 and 2024, hovering around 61–65%.

Outlook for the Next Decade: We expect to see increased M&A activity, driving greater specialization and value realization.

Genetic engineering remains the primary growth driver of the global seed industry.

Despite the emergence of new terms such as gene editing, artificial intelligence, and whole-genome selection breeding, transgenic technology remains the most stable and reliable driver of growth over the next decade.

Why is the adoption of genetic engineering still growing rapidly? Several factors explain this trend: new-generation stacked traits are emerging at an accelerated pace, and technologies offering “multi‑insurance” against pests, herbicides, and environmental stresses have reached maturity; globally, genetically modified crops are concentrated primarily in three major industrial crops—corn, soybeans, and cotton; and while the impact of GM technology is substantial, its commercialization cycle is lengthy, spanning from regulatory approval and backcross breeding to variety registration and finally to large‑scale market deployment—a process that typically takes farmers six to seven years. This helps account for why many GM traits received safety approvals in 2024, yet their full market impact will not be felt until around 2030.

The commercial rationale behind genetic engineering is clear: stability, precision, and scalability form the foundational pillars of food security.

Gene editing and related technologies: hold enormous potential, but the biggest variable remains regulation.

Unlike genetic engineering, which has long emphasized pest resistance, herbicide tolerance, and yield increases, technologies such as gene editing are now making inroads into the food supply chain. Looking ahead, the focus of gene-editing and related technologies is shifting from the “field” to the “food product.”

The global distribution of 977 NBT (such as gene editing) projects under development is more balanced, encompassing input‑related, agronomic, and processor/consumer‑oriented traits, with trait diversity being introduced into staple crops including rice and wheat. NBTs (such as gene editing) have the potential to transform the entire food value chain, not just the agricultural sector.

The biggest challenge in gene editing today is the fragmented global regulatory landscape. Currently, the international regulatory framework is characterized by a three‑pronged divide: 27 countries treat it as conventional breeding (e.g., the United States, Japan, the United Kingdom, and India); 12 countries regulate it as a GMO (e.g., the European Union); and six countries still lack a clear regulatory framework.

In a nutshell: the future of NBTs—such as gene editing—is not a technological issue but a political one. The pace of policy and regulatory oversight will determine how quickly the industry takes off.

The value of traits is shifting from the field to the dinner table.

The seed industry has never been closer to the heart of the food sector than it is today. Traditionally, the value of the seed industry was concentrated at the farmer‑level planting stage; however, the modern seed industry’s value chain has been significantly extended. According to Dr. Bharti Malhotra’s analysis, the value of traits is now spilling over and reshaping the agricultural value chain.

This means that the seed industry is transitioning from an “agricultural input” to the “source of food technology.” Whoever controls genetic traits holds the power of discourse in the food chain. In the future, food companies will become increasingly closely integrated with cutting-edge breeding technologies.

China: Standing at a Critical Juncture for Reshaping the Global Seed Industry Landscape

The report explicitly states: “The commercial cultivation of genetically modified corn in China will significantly alter the global market structure.”

The reasons are straightforward: China accounts for roughly 20% of global corn acreage, and its ability to ensure stable yields will shape the trajectory of international corn trade. Meanwhile, China is transitioning from a major demand‑driven market to a technology‑leading powerhouse: the commercial cultivation of genetically modified corn and advances in gene editing are poised to shift China’s role from a “market” to a “technology hub.” Major global agribusinesses are undertaking comprehensive strategic realignments, with Bayer, Corteva, and Syngenta all repositioning their strategies in the Chinese market. At the same time, China’s seed industry has entered a window of technological leapfrogging, with multiple cutting‑edge approaches—such as two‑line hybrid seed production, gene editing, and direct‑seeding rice—being advanced in parallel.

Over the next decade, every regulatory change in China will reshape the global seed industry.

Five Major Industry Outlooks for the Next Decade

Based on global trends, he offers five observations:

The dominant position of genetic engineering in major staple crops will remain unshaken, with corn, soybeans, cotton, and canola continuing to be the core battlegrounds for GM technology. Breakthroughs in gene‑editing and related technologies are likely to emerge first in food crops and vegetables, with rice, wheat, tomatoes, and potatoes showing the greatest potential for rapid adoption. The technological value chain will shift from the “field” to the “kitchen” and the “supermarket,” and future consumer demand will, in turn, drive breeding objectives. The degree of global regulatory harmonization will determine the pace of commercialization for gene editing; only when major economies reach a broad industry consensus will this field truly take off. China is poised to become a pivotal force shaping the global seed‑industry landscape.

Summary

In the new decade, competition in the seed industry boils down to a contest between “technological insight” and “strategic resolve.” In this era shaped by technology, regulation, and the strategic interests of major powers, whoever first transitions from a “farming mindset” to a “technology‑and‑food‑chain mindset” will be poised to secure the future.

For industry giants, the challenge lies in balancing the “certainty of benefits” offered by genetic modification with the “disruptive potential” of gene editing.

For small and medium-sized enterprises, the key to survival lies in “mastering technology precisely, thoroughly understanding regulatory requirements, and strategically positioning oneself within the value chain.” Focusing on niche traits and aligning with specific food‑industry needs—alongside pharmaceutical applications—provides a clear path forward; the IPO of First Blood Rice by Heyuan Bio serves as an excellent example.

Only by leveraging regulatory differences to expand technology overseas—such as conducting field‑scale validation in the policy‑friendly UK—can companies secure an irreplaceable foothold in this round of industry restructuring.

Ultimately, all players—regardless of size—must recognize a fundamental reality: driven by new technologies, the value chain for seeds has been dramatically extended, linking fields directly to consumers’ tables. Whoever first builds core competencies around this reality will be best positioned to secure their future in the next wave of global seed‑industry restructuring.

Source: S&P Global Commodity Insights, "Trends in the Global Seed Market", Dr Bharti Malhotra.

Source: WeChat Official Account: NOVOSEED